MYC and colorectal cancer: However, a recent study examining metabolic changes across colorectal cancer progression in human tissue found that although mutations were found throughout the cancer stages, these mutations were not associated with metabolite levels in the tissue and that metabolic reprogramming was caused primarily by aberrant MYC expression [41].